 |
| Aventis bites Sanofi bait |
| Offer raised to $65 billion, deal to create third-largest drug company |
| Aventis, the French-German drug company, on Sunday night accepted a sweetened offer from once-hostile bidder Sanofi-Synthelabo, in a deal that values Aventis at €55 billion ($65 billion), sources close to the negotiations said. ... |
Read.. |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
 |
|
| Sanofi chairman Jean-Francois Dehecq (left) with Aventis chief Igor Landau in Paris on Monday. (AFP) |
|
|
|
| |
| |
|